Accelerate Diagnostics, Inc.
Hedge Funds Holdings
Last updated:
Accelerate Diagnostics, Inc.‘s stocks are currently a part of 68 hedge funds’ portfolios, which represents 34.02% of the total amount of its stocks outstanding. This makes up a total of 25.93M shares of Accelerate Diagnostics, Inc.. Compared to the previous quarter, the number grew by 38.71% or 7.23M shares more. As for the holding position changes, 20.59% (14) of current hedge fund investors increased the number of shares held, 14.71% (10) of current holders sold a part of the shares held, and 10.29% (7) closed the holdings completely. 19 hedge funds are new holders of Accelerate Diagnostics, Inc. stock in Q3 2022, it is 27.94% of total holders.
Hedge funds holding Accelerate Diagnostics (Q4 2017 – Q3 2022)
| Q4 2017 | 115 |
|---|---|
| Q1 2018 | 115 |
| Q2 2018 | 116 |
| Q3 2018 | 118 |
| Q4 2018 | 106 |
| Q1 2019 | 113 |
| Q2 2019 | 116 |
| Q3 2019 | 112 |
| Q4 2019 | 107 |
| Q1 2020 | 108 |
| Q2 2020 | 121 |
| Q3 2020 | 113 |
| Q4 2020 | 114 |
| Q1 2021 | 99 |
| Q2 2021 | 92 |
| Q3 2021 | 104 |
| Q4 2021 | 103 |
| Q1 2022 | 101 |
| Q2 2022 | 67 |
| Q3 2022 | 68 |
Hedge funds changes in Accelerate Diagnostics positions (Q4 2017 – Q3 2022)
| Q4 2017 | 23 | 29 | 37 | 24 | 2 |
|---|---|---|---|---|---|
| Q1 2018 | 14 | 33 | 31 | 14 | 23 |
| Q2 2018 | 13 | 36 | 33 | 12 | 22 |
| Q3 2018 | 11 | 41 | 28 | 9 | 29 |
| Q4 2018 | 10 | 36 | 32 | 22 | 6 |
| Q1 2019 | 20 | 29 | 31 | 12 | 21 |
| Q2 2019 | 17 | 39 | 23 | 12 | 25 |
| Q3 2019 | 15 | 34 | 26 | 19 | 18 |
| Q4 2019 | 13 | 30 | 28 | 18 | 18 |
| Q1 2020 | 14 | 31 | 28 | 10 | 25 |
| Q2 2020 | 24 | 44 | 21 | 9 | 23 |
| Q3 2020 | 9 | 29 | 36 | 19 | 20 |
| Q4 2020 | 16 | 41 | 24 | 15 | 18 |
| Q1 2021 | 5 | 35 | 36 | 18 | 5 |
| Q2 2021 | 9 | 27 | 30 | 18 | 8 |
| Q3 2021 | 17 | 27 | 34 | 4 | 22 |
| Q4 2021 | 12 | 46 | 24 | 14 | 7 |
| Q1 2022 | 13 | 28 | 30 | 14 | 16 |
| Q2 2022 | 13 | 12 | 21 | 45 | -24 |
| Q3 2022 | 19 | 14 | 10 | 7 | 18 |
Hedge funds changes in Accelerate Diagnostics stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 12,662,000 | 17,562,000 |
|---|---|---|
| Q1 2018 | 5,633,000 | 14,298,000 |
| Q2 2018 | 23,513,000 | 13,674,000 |
| Q3 2018 | 27,257,000 | 13,266,000 |
| Q4 2018 | 9,003,000 | 6,398,000 |
| Q1 2019 | 16,983,000 | 10,771,000 |
| Q2 2019 | 10,207,000 | 8,760,000 |
| Q3 2019 | 9,497,000 | 8,014,000 |
| Q4 2019 | 5,367,000 | 8,496,000 |
| Q1 2020 | 1,561,000 | 2,107,000 |
| Q2 2020 | 5,306,000 | 5,556,000 |
| Q3 2020 | 1,182,000 | 2,464,000 |
| Q4 2020 | 185,000 | 2,059,000 |
| Q1 2021 | 1,105,000 | 2,020,000 |
| Q2 2021 | 1,125,000 | 1,305,000 |
| Q3 2021 | 270,000 | 934,000 |
| Q4 2021 | 109,000 | 1,009,000 |
| Q1 2022 | 18,000 | 229,000 |
| Q2 2022 | 34,000 | 828,000 |
| Q3 2022 | 190,000 | 648,000 |